These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24997180)

  • 1. The role of social deprivation in severe neovascular age-related macular degeneration.
    Sharma HE; Mathewson PA; Lane M; Shah P; Glover N; Palmer H; Haque MS; Denniston AK; Tsaloumas MD
    Br J Ophthalmol; 2014 Dec; 98(12):1625-8. PubMed ID: 24997180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration.
    Finger RP; Guymer RH; Gillies MC; Keeffe JE
    Ophthalmology; 2014 Jun; 121(6):1246-51. PubMed ID: 24518613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracing the natural course of visual acuity and quality of life in neovascular age-related macular degeneration: a systematic review and quality of life study.
    Elshout M; Webers CA; van der Reis MI; de Jong-Hesse Y; Schouten JS
    BMC Ophthalmol; 2017 Jul; 17(1):120. PubMed ID: 28693519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of the neurosensory retina after macular translocation surgery is independent of preoperative macular sensitivity in neovascular age-related macular degeneration.
    Mettu PS; Sarin N; Stinnett SS; Toth CA
    Retina; 2011 Sep; 31(8):1637-49. PubMed ID: 21775925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK.
    Keenan TD; Kelly SP; Sallam A; Mohamed Q; Tufail A; Johnston RL
    Br J Ophthalmol; 2013 Sep; 97(9):1168-72. PubMed ID: 23813420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study.
    Tufail A; Patel PJ; Egan C; Hykin P; da Cruz L; Gregor Z; Dowler J; Majid MA; Bailey C; Mohamed Q; Johnston R; Bunce C; Xing W;
    BMJ; 2010 Jun; 340():c2459. PubMed ID: 20538634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial.
    Rakoczy EP; Lai CM; Magno AL; Wikstrom ME; French MA; Pierce CM; Schwartz SD; Blumenkranz MS; Chalberg TW; Degli-Esposti MA; Constable IJ
    Lancet; 2015 Dec; 386(10011):2395-403. PubMed ID: 26431823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration.
    Mruthyunjaya P; Stinnett SS; Toth CA
    Ophthalmology; 2004 Sep; 111(9):1715-24. PubMed ID: 15350328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyes.
    Zarranz-Ventura J; Liew G; Johnston RL; Xing W; Akerele T; McKibbin M; Downey L; Natha S; Chakravarthy U; Bailey C; Khan R; Antcliff R; Armstrong S; Varma A; Kumar V; Tsaloumas M; Mandal K; Bunce C; Tufail A;
    Ophthalmology; 2014 Oct; 121(10):1966-75. PubMed ID: 24953791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neovascular age-related macular degeneration associated with no light perception.
    Brown GC; Basha MM; Brown MM
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):229-34. PubMed ID: 25707049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual outcomes in relation to time to treatment in neovascular age-related macular degeneration.
    Rasmussen A; Brandi S; Fuchs J; Hansen LH; Lund-Andersen H; Sander B; Larsen M
    Acta Ophthalmol; 2015 Nov; 93(7):616-20. PubMed ID: 26073051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.
    Dunavoelgyi R; Sacu S; Eibenberger K; Palkovits S; Leydolt C; Pruente C; Schmidt-Erfurth U
    Retina; 2012 Sep; 32(8):1471-9. PubMed ID: 22414958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
    Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
    Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Results of Full Macular Translocation for Choroidal Neovascularization in Age-Related Macular Degeneration.
    van Romunde SH; Polito A; Bertazzi L; Guerriero M; Pertile G
    Ophthalmology; 2015 Jul; 122(7):1366-74. PubMed ID: 25881514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.
    Dong LM; Childs AL; Mangione CM; Bass EB; Bressler NM; Hawkins BS; Marsh MJ; Miskala P; Jaffee HA; McCaffrey LA;
    Am J Ophthalmol; 2004 Jul; 138(1):91-108. PubMed ID: 15234287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting.
    Boulanger-Scemama E; Querques G; About F; Puche N; Srour M; Mane V; Massamba N; Canoui-Poitrine F; Souied EH
    J Fr Ophtalmol; 2015 Sep; 38(7):620-7. PubMed ID: 25913443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab.
    Bressler NM; Chang TS; Varma R; Suñer I; Lee P; Dolan CM; Ward J; Ianchulev T; Fine J
    Ophthalmology; 2013 Jan; 120(1):160-8. PubMed ID: 23009891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration.
    Shah VP; Shah SA; Mrejen S; Freund KB
    Retina; 2014 Jul; 34(7):1281-8. PubMed ID: 24695062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.